
Tropicam1%
Aristopharma Ltd.
Tropicamide is an anticholinergic (antimuscarinic) ophthalmic agent used to produce short-acting mydriasis (pupil dilation) and cycloplegia (temporary paralysis of accommodation) for diagnostic eye…
Tropicamide is an anticholinergic (antimuscarinic) ophthalmic agent used to produce short-acting mydriasis (pupil dilation) and cycloplegia (temporary paralysis of accommodation) for diagnostic eye examinations.
Tropicamide is not intended for the treatment of any ocular disease; it is a diagnostic aid only.
| Indication | Recommended Dosing |
|---|---|
| Mydriasis for fundus examination (adults and children) | Instill 1 drop of 0.5% or 1% Tropicamide solution into the conjunctival sac; may repeat once after 5 minutes if adequate dilation is not achieved. Examination is usually performed 15-20 minutes after instillation. |
| Cycloplegic refraction | Instill 1 drop of 1% Tropicamide solution, repeated once after 5 minutes; refraction is generally performed 20-30 minutes after the second instillation. Combination with a longer-acting cycloplegic (e.g., cyclopentolate) may be used per physician judgment when deeper cycloplegia is required. |
| Prior to laser or minor diagnostic ophthalmic procedures | As directed by the ophthalmologist, often in combination with phenylephrine for more complete dilation. |
For use by, or under the direct supervision of, a qualified eye-care professional only.
Ocular side effects are most common and are usually transient:
Systemic anticholinergic effects are uncommon with recommended ophthalmic dosing of Tropicamide but may occur, particularly in infants, young children, and with excessive or repeated dosing:
Tropicamide is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.